Medical analytics & innovation.
Never before has there been a time when more robust data, content, and opinions are readily at our disposal. Medical Analytics and Innovation operate at the center of this, working to turn an information deluge into actionable insight.
What we do.
We work with life sciences companies at all stages of growth and development to deliver advanced outcomes at the intersection of medical strategy, advanced analytics, and digital innovation, including AI and Generative AI.
By leveraging data and technology, we uncover insights that speed the time to better strategic decisions and engagements and help enhance and measure impact within the spectrum of medical-led tactics.
About us.
Our Medical Analytics and Innovation team offers deep expertise across a wide range of services, including medical strategy, advanced medical analytics, digital innovation, and technology consulting, including AI and GenAI, for Medical Affairs and commercial teams.
Our core capabilities include:
- Actionable Analytics: Cut through the complexity of your therapeutic space and make quicker, insight-driven strategic decisions with more impact.
- Digital Innovation: Engage with your data more effectively, uncover more meaningful insights from your interactions, deliver superior customer experiences, and support the unique needs of medical-lead teams with our integrated suite of digital products.
- Medical Strategy: Unrivalled expertise in leveraging advanced analytics to drive directional insights and targeted medical strategy recommendations.
- Enterprise Enablement: Re-orient how your team thinks about digital innovation and analytics and inspire, guide, and activate them toward using technology in an impactful way.
Meet the medical analytics and innovation team.
Navigate this carousel with the arrows.
Latest thinking across MEDiSTRAVA.
We are thought leaders in the industry, driving the conversation and challenging our peers.
Read more about what our experts have to say.
-
Read more
Personalized Medicine and Biomarkers: Applications, Challenges, and Future Directions
The traditional "one-size-fits-all" concept is shifting towards a more customized approach in personalized or precision medicine (PM),
-
Read more
MEDiSTRAVA is now PIF TICK certified as a Trusted Information Creator
The MEDiSTRAVA Patient Engagement team were recently awarded the PIF TICK – the only independently assessed quality...
-
Read more
Beyond the Omnichannel Buzzword: Crafting Smarter Engagement in Medical Affairs
Introduction Let’s face it: “Omnichannel”, as a term, is overused. We’re all tired of it. Especially in...
-
Read more
Prevalence of Soft Tissue Sarcoma (STS) Subtypes in the US, Risk of Metastases at Diagnosis, and Survival Outcomes.
Soft tissue sarcomas (STS) are heterogeneous malignancies with diverse clinical presentations and outcomes. This study...
Related solutions.
Contact us.
Learn more about MEDiSTRAVA’s strategic solutions and how we can help your business tackle the unique and evolving needs of leadership and Medical teams.